Table 1: Comparison of patient characteristics between liposomal bupivacaine and standard bupivacaine groups.
|
LB |
SB |
p |
Number of Subjects |
40 |
40 |
|
|
|
|
|
Age (mean ± SD) |
57.1 ± 14.1 |
63.1 ± 8.6 |
0.0256 |
|
|
|
|
Male |
21 (52.5%) |
24 (60.0%) |
0.4990 |
Female |
19 (47.5%) |
16 (40.0%) |
|
|
|
|
|
Diabetes |
5 (12.5%) |
6 (15.0%) |
0.7454 |
COPD |
4 (10.0%) |
2 (5.0%) |
0.6752 |
CAD |
1 (2.5%) |
5 (12.5%) |
0.2007 |
Chronic pain requiring daily opioid |
2 (5.0%) |
0 |
0.4397 |
|
|
|
|
BMI (mean ± SD) |
31.6 ± 6.1 |
31.3 ± 5.8 |
0.7956 |
|
|
|
|
Arthroscopy |
31 (77.5%) |
30 (75.0%) |
0.7928 |
Arthroplasty |
9 (22.5%) |
10 (25.0%) |
|
Abbreviations: LB: Liposomal Bupivacaine; SB: Standard Bupivacaine; SD: Standard Deviation; COPD: Chronic Obstructive Pulmonary Disease; CAD: Coronary Artery Disease; BMI: Body Mass Index